ESTIMATING THE FRACTION REABSORBED IN DRUGS UNDERGOING ENTEROHEPATIC CIRCULATION

被引:37
作者
TSE, FLS
BALLARD, F
SKINN, J
机构
来源
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS | 1982年 / 10卷 / 04期
关键词
D O I
10.1007/BF01065175
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:455 / 461
页数:7
相关论文
共 9 条
[1]   INFLUENCE OF GUT MICROFLORA ON BIOAVAILABILITY [J].
BOXENBAUM, HG ;
BEKERSKY, I ;
JACK, ML ;
KAPLAN, SA .
DRUG METABOLISM REVIEWS, 1979, 9 (02) :259-279
[2]   PHARMACOKINETICS OF DRUGS SUBJECT TO ENTEROHEPATIC CIRCULATION [J].
CHEN, HSG ;
GROSS, JF .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1979, 68 (06) :792-794
[3]  
COLBURN WA, 1979, DRUG METAB DISPOS, V7, P100
[5]   PHARMACOKINETIC INTERPRETATION OF THE ENTEROHEPATIC RECIRCULATION AND 1ST-PASS ELIMINATION OF MORPHINE IN THE RAT [J].
DAHLSTROM, BE ;
PAALZOW, LK .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1978, 6 (06) :505-519
[6]   THEORETICAL-EXAMINATION OF EFFECTS OF GUT WALL METABOLISM, HEPATIC ELIMINATION, AND ENTEROHEPATIC RECYCLING ON ESTIMATES OF BIOAVAILABILITY AND OF HEPATIC BLOOD-FLOW [J].
PANG, KS ;
GILLETTE, JR .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1978, 6 (05) :355-367
[8]  
TSE FLS, 1982, J PHARMACOL METHOD, V7, P139, DOI 10.1016/0160-5402(82)90026-2
[9]  
TSE FLS, J PHARM PHARM